User profiles for Balazs Murnyak
Balazs MurnyakHigh-Throughput Genomics / Huntsman Cancer Institute Verified email at utah.edu Cited by 506 |
[HTML][HTML] Immunohistochemical correlates of TP53 somatic mutations in cancer
B Murnyák, T Hortobágyi - Oncotarget, 2016 - ncbi.nlm.nih.gov
Despite controversy on the correlation between p53 accumulation and TP53 mutational
status, ihas long been used as a surrogate method for mutation analysis. The aim of our study …
status, ihas long been used as a surrogate method for mutation analysis. The aim of our study …
[HTML][HTML] Pathophysiology of meningioma growth in pregnancy
Meningioma is among the most frequent brain tumours predominantly affecting elderly women.
Epidemiological studies have shown that at the age of fertility the incidence is relatively …
Epidemiological studies have shown that at the age of fertility the incidence is relatively …
[HTML][HTML] PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
B Murnyák, MC Kouhsari, R Hershkovitch, B Kálmán… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Overexpression of PARP1 exists in various cancers, including glioblastoma (GBM). Although
PARP1 inhibition is a promising therapeutic target, no comprehensive study has addressed …
PARP1 inhibition is a promising therapeutic target, no comprehensive study has addressed …
[HTML][HTML] Epigenetics of meningiomas
Meningiomas account for one-third of all adult central nervous system tumours and are divided
into three WHO grades. In contrast to the relatively well characterized genetic alterations, …
into three WHO grades. In contrast to the relatively well characterized genetic alterations, …
[HTML][HTML] Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma
Since the initial discovery of recurrent isocitrate dehydrogenase 1 (IDH1) mutations at
Arg132 in glioma, IDH1 hotspot mutations have been identified in cholangiocarcinoma, …
Arg132 in glioma, IDH1 hotspot mutations have been identified in cholangiocarcinoma, …
Molecular subgroups of glioblastoma–an assessment by immunohistochemical markers
Á Nagy, F Garzuly, G Padányi, I Szűcs… - Pathology & Oncology …, 2019 - Springer
Comprehensive molecular characterization of and novel therapeutic approaches to glioblastoma
have been explored as a result of advancements in biotechnologies. In this study, we …
have been explored as a result of advancements in biotechnologies. In this study, we …
Poly (ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas
Meningiomas are one of the most frequent intracranial tumours, with 13 histological types and
three grades according to the 2007 WHO Classification of Tumours of the Central Nervous …
three grades according to the 2007 WHO Classification of Tumours of the Central Nervous …
Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence
Although tumour recurrence is an important and not infrequent event in meningiomas, predictive
immunohistochemical markers have not been identified yet. The aim of this study was to …
immunohistochemical markers have not been identified yet. The aim of this study was to …
Molecular pathology of meningiomas
Meningiomas represent nearly one-third of all adult primary brain tumours. According to
their clinical and histologic appearance, they can be divided into WHO grades I-III. Almost 90% …
their clinical and histologic appearance, they can be divided into WHO grades I-III. Almost 90% …
Haemorrhagic transformation in ischaemic stroke is more frequent than clinically suspected–A neuropathological study
Objectives The vast majority of literature on the frequency of the haemorrhagic transformation
of ischaemic stroke is based on imaging studies. The purpose of the present study was to …
of ischaemic stroke is based on imaging studies. The purpose of the present study was to …